The role of the endocannabinoid system in managing neuropsychiatric symptoms in Alzheimer’s disease
Abstract The endocannabinoid system comprises cannabinoid receptors (CBRs) 1 & 2, endocannabinoids (eCBs) anandamide (AEA) and 2-arachidonoylglycerol (2-AG), and the…
